Modulatory Effects of Multichannel tDCS During Prolonged Experimental Pain
Effects of Non-invasive Brain Stimulation Methods in Experimentally Induced Pain
1 other identifier
interventional
38
1 country
1
Brief Summary
Corticomotor excitability, pain sensitivity, descending pain control and somatosensory evoked potentials (SEPs) is often altered in acute and chronic pain. Topical capsaicin generates stable, long-lasting hyperalgesia and ongoing tonic pain in healthy participants, which significantly inhibits corticomotor excitability in the primary motor cortex (M1). Recent studies (by Fischer et al 2017) indicated that multifocal Transcranial Direct Current Stimulation (tDCS) administered to brain regions linked to the resting state motor network (network-tDCS) could enhance corticomotor excitability in healthy participants compared to single site M1-tDCS. It remains unknown whether network-tDCS has also the potential to modulate the inhibitory effects on motor cortex excitability, pain sensitivity, descending pain control and SEPs associated with prolonged pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
November 14, 2019
CompletedFirst Posted
Study publicly available on registry
November 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedJune 24, 2020
June 1, 2020
9 months
November 14, 2019
June 23, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Corticomotor excitability
Corticomotor excitability is expressed as the peak-to-peak amplitude of motor evoked potentials to single-pulse transcranial magnetic stimulation. It is expected that network-tDCS will reduce corticomotor inhibition induced by tonic pain during 24 hours.
24 hours
Secondary Outcomes (7)
Conditioned pain modulation effect
24 hours
Warm detection thresholds (sensitivity measure)
24 hours
Heat pain thresholds (pain sensitivity measure)
24 hours
Mechanical pain thresholds (pain sensitivity measure)
24 hours
Cuff pressure pain sensitivity
24 hours
- +2 more secondary outcomes
Study Arms (2)
Sham transcranial direct current stimulation (sham tDCS)
SHAM COMPARATORThis study has a parallel design and 2 groups: Active tDCS and Sham tDCS. Sham tDCS applies a standard sham protocol consisting of ramping up and down during 30 seconds at the beginning and at the end of each tDCS session. Each tDCS session lasts 20 minutes and applies a total current of 4mA.
Active transcranial direct current stimulation (activetDCS)
ACTIVE COMPARATORThe active comparator is the Active tDCS group. The active tDCS will target the resting-state motor network and will apply a distributed direct current during the whole session. (The TIME during the direct current is applied is the only difference with Sham tDCS) Each tDCS session lasts 20 minutes and applies a total current of 4mA.
Interventions
Transcranial direct current stimulation delivers a low intensity current of up to 4 mA per session through small and circular shaped electrodes applied over the scalp. This induces a weak but focal electrical field that may modify the excitability of the underlying cortical target in a polarity and activity dependent fashion.
Eligibility Criteria
You may qualify if:
- Right-handed healthy men and women in the age 21-50 years who speak and understand English
You may not qualify if:
- Lack of ability to cooperate
- History of chronic pain or current acute pain
- Pregnancy
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Present and previous neurologic, musculoskeletal or mental illnesses
- Chili allergies (subproject 1 and 2)
- Current use of medications that may affect the trial
- Previous experience with rTMS and tDCS
- Contraindications to rTMS application (history of epilepsy, metal implants in head or jaw, etc.)
- Failure to pass the questionnaire for tDCS
- Failure to pass the "TASS questionnaire" (TASS = Transcranial Magnetic Stimulation Adult Safety Screen) (Rossi et al., 2001)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aalborg University
Aalborg, Nordylland, 9000, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Graven-Nielsen, PhD
Aalborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Fellow
Study Record Dates
First Submitted
November 14, 2019
First Posted
November 18, 2019
Study Start
March 1, 2019
Primary Completion
November 30, 2019
Study Completion
February 28, 2020
Last Updated
June 24, 2020
Record last verified: 2020-06